This Article Full Text (PDF) Other Versions of this Article: JCM.02271-07v1 46/4/1292    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zhang, W. Articles by Kuczius, T. Search for Related Content PubMed PubMed Citation Articles by Zhang, W. Articles by Kuczius, T.

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.02271-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

A New Immuno-PCR Assay for the Detection of Low Concentrations of Shiga Toxin 2 and Its Variants

Institute of Hygiene and the National Consulting Laboratory on Hemolytic Uremic Syndrome, University of Münster, Robert Koch Str. 41, 48149 Münster, Germany; Governmental Institute of Public Health of the Lower Saxony, Roesebeckstr. 4-6, 30449 Hannover, Germany; Institute of Medical Microbiology, University of Münster, Domagkstr. 10, 48149 Münster, Germany
Institute of Hygiene and the National Consulting Laboratory on Hemolytic Uremic Syndrome, University of Münster, Robert Koch Str. 41, 48149 Münster, Germany; Governmental Institute of Public Health of the Lower Saxony, Roesebeckstr. 4-6, 30449 Hannover, Germany; Institute of Medical Microbiology, University of Munster, Domagkstr. 10, 48149 Münster, Germany

^* To whom correspondence should be addressed. Email: tkuczius{at}uni-muenster.de.

	Abstract

Shiga toxin (Stx)-producing Escherichia coli (STEC) strains secrete toxins that are major virulence factors and diagnostic targets, but some STEC secrete Stx in amounts that cannot be detected using conventional cell cytotoxicity or immunological assays. Therefore, there is an urgent need for more sensitive Stx detection methods. We describe the development of an assay that can detect low concentrations of Stx2 and its variants. An immuno-PCR Stx2 assay was developed based on an enzyme immunoassay (EIA) combining antibody capture and DNA amplification to increase the signal. The immuno-PCR assay detected 10 pg/ml of purified Stx2, compared to 1 ng/ml detectable by commercial EIA. Consequently, immuno-PCR detected Stx2 and its variants in STEC strains that produce the toxins at levels non-detectable using the EIA, as well as Stx2 in EIA-negative enriched stool cultures from patients. Our data demonstrate that the immuno-PCR developed here is a highly sensitive and specific method for the detection of trace amounts of Stx2 and Stx2 variants. It is therefore suitable for clinical microbiological laboratories to improve the toxin detection in clinical samples.